ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

TMO // Thermo Fisher Scientific Inc

FA <GO> NYSE RQD COCKPIT → CIK 0000097745 ↗
Industrials • Industrial Machinery/Components
$697.00 ▼ -12.18 (-1.72%)
MKT CAP: $262.22B • VOL: 2.09M
TMO // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
LINE ITEM (USD / %)
FY 2025
FILED 2025-12-31
FY 2024
FILED 2024-12-31
FY 2023
FILED 2023-12-31
Revenue (Total Sales) $44.56B $42.88B $42.86B
YoY Revenue Growth % +3.9% +0.1% —
Gross Profit — — —
Gross Margin % — — —
Research & Development (R&D) — — —
Operating Income (EBIT) $7.75B $7.34B $6.86B
Operating Margin % 17.4% 17.1% 16.0%
Net Income (GAAP) $6.72B $6.34B $5.96B
EBITDA (Normalized) $8.97B $8.46B $8.40B
Diluted EPS ($/sh) — — —
Operating Cash Flow (OCF) $7.82B $8.67B $8.41B
Capital Expenditures (CapEx) $1.52B $1.40B $1.93B
Free Cash Flow (FCF) $6.29B $7.27B $6.48B
FCF Margin % 14.1% 16.9% 15.1%
Return on Invested Capital (ROIC %) 8.8% 8.5% 6.2%
Cash & Short-Term Equivalents $9.85B $4.01B —
Total Debt (Short + Long Term) $25.82B $22.77B $33.75B
Total Stockholders' Equity $53.41B $49.58B $69.23B